Mandate renewed for Canada-wide drug safety consortium based at the LDI
A renewed five-year mandate has been granted to a national consortium on prescription drug safety that is headquartered in the Lady Davis Institute at the JGH.
Research roundup
Dr. Roderick McInnes, Director of the Lady Davis Institute at the JGH, has received the 2015 Award for Excellence in Human Genetics Education from the American Society of Human Genetics.
Link found between pain reliever
and hypoglycemia
Tramadol, a weak opioid for treating moderate to moderately severe pain, can be linked in some cases to an increased risk of hospitalization for hypoglycemia, concludes a study by a team of epidemiologists in the Lady Davis Institute at the JGH.